T1	Participants 66 79	rib fractures
T2	Participants 176 215	pulmonary morbidity after rib fractures
T3	Participants 272 537	study was conducted spanning January 2003 to June 2011 assessing pneumonia within 30 days and potential adverse effects of ketorolac among all patients with rib fractures who received ketorolac <4 days after injury compared with a random sample of those who did not
T4	Participants 958 1008	gastrointestinal hemorrhage, and fracture nonunion
T5	Participants 1078 1105	patients with rib fractures
